DMT Drug Street Names: A Clinician’s Guide to the Common Names, Slang, Formulations, and Recognising DMT Use

What DMT is in pharmacological terms, the wide range of street names and slang terms used for it including the spirit molecule, businessman’s trip, fantasia, changa, and dimitri, how to recognise the different formulations including DMT vape pens and ayahuasca brews, the typical patterns of use, and the addiction and mental health risks that parents, partners, and clinicians should be aware of.

Clinically reviewed by Dr. Ponlawat Pitsuwan, Physician and Addiction Medicine Specialist, Phuket Island Rehab.

DMT is N,N-dimethyltryptamine, a powerful naturally-occurring hallucinogenic compound found in many plants and in trace amounts in the human body. The most common street names include the spirit molecule, businessman’s trip or businessman’s lunch, fantasia, dimitri, the god molecule, and 45-minute psychosis. The substance is sold in several distinct formulations including crystalline DMT for smoking or vaporising, DMT vape pens or DMT carts that contain pre-loaded liquid solution, changa which combines smokable DMT with herbal blends, ayahuasca which is a brewed combination of DMT-containing plants with monoamine oxidase inhibitors, and 5-MeO-DMT which is chemically related and produces a different experiential profile. The duration of effects depends on the formulation: smoked or vaporised DMT produces an intense experience lasting 15 to 45 minutes, while ayahuasca produces a four to six hour ceremonial experience. Although DMT has lower abuse liability than stimulants and opioids, regular use can produce psychological dependence, contribute to hallucinogen persisting perception disorder, precipitate or worsen serious mental illness in vulnerable individuals, and lead to dangerous behaviour during the acute intoxication. Recognising the street names and formulations is the first step for families and clinicians who suspect DMT use.

What DMT is and why it matters

N,N-dimethyltryptamine, abbreviated as DMT, is one of the most potent hallucinogenic compounds known. The molecule is a tryptamine that binds with high affinity to the serotonin 5-HT2A receptor, the same receptor that mediates the psychoactive effects of LSD, psilocybin from psilocybin mushrooms, and mescaline. DMT occurs naturally in many plants used in traditional South American ceremonial practice, including Psychotria viridis, Diplopterys cabrerana, and Mimosa hostilis, and is found in trace amounts in the cerebrospinal fluid and pineal gland of many mammals including humans, though the biological function of endogenous DMT is not fully understood.

The compound was first synthesised in 1931 and was characterised pharmacologically by Stephen Szara in the 1950s. The Schedule I classification by the United States Drug Enforcement Administration in 1970 reflects the federal assessment of high abuse potential and no accepted medical use, though clinical research has been resumed in the past decade examining DMT and related compounds for potential applications in treatment-resistant depression, post-traumatic stress disorder, and end-of-life anxiety. The substance remains illegal for non-research use in most countries, though some jurisdictions permit religious use of ayahuasca through limited exemptions for established traditions.

The reason DMT street names matter for clinicians and families is that the substance is increasingly available outside of traditional ceremonial contexts, particularly in concentrated form as crystalline DMT or as pre-loaded DMT vape pens. The patterns of use have changed substantially since the 2010s, with younger users obtaining the substance through online sources, festival circuits, and peer networks, and using it casually rather than in the sacred ceremonial setting that has historically governed use. Recognising the slang terms and the typical formulations is essential for early identification of use and for clinical assessment when the use has produced problems.

The common street names for DMT

DMT has acquired more street names than most controlled substances, reflecting its decades-long history in the counterculture, the religious or spiritual framing that many users give to the experience, and the multiple distinct formulations in which it is sold. The single most widely used name is simply DMT, used by users themselves, in online forums, and in academic literature. Beyond this, several alternative names appear repeatedly in conversation and in seizure reports.

The spirit molecule is perhaps the most culturally prominent name, popularised by Dr. Rick Strassman’s 1990s human DMT research and the subsequent book and documentary of the same title. The name reflects the spiritual or mystical framing that many users give to the experience and is used by people who consider DMT a sacrament rather than a recreational drug. The god molecule is used in similar contexts and reflects the experience that many users report of contacting what feels like a divine intelligence during the trip. Both terms tend to indicate a user who frames the substance in religious or spiritual terms.

Businessman’s trip and businessman’s lunch are widely used terms that refer to the short duration of the smoked DMT experience, typically 15 to 30 minutes including come-up, peak, and return. A user can smoke DMT during a lunch break and return to work, in theory, though in practice the depth of the experience usually requires longer recovery. The names are typically used by people who use the substance casually and recreationally rather than in a ceremonial frame.

Dimitri is a casual nickname derived from DMT itself and is heard in younger user populations and in festival contexts. Fantasia, the businessman’s special, and 45-minute psychosis are other terms in circulation. The phrase 45-minute psychosis was coined by users themselves to describe the temporary nature of the intense experience and is sometimes used with self-aware humour in trip reports.

Aya, ayahuasca, the medicine, the vine, and the tea refer specifically to ayahuasca rather than to pure DMT, but the distinction is not always clear in user reports and in seizure descriptions. Vine of the soul is a translation of the Quechua name yagé and refers to the same brew. Hoasca is the term used by the Brazilian União do Vegetal religious community, who use ayahuasca as a sacrament under legal exemption in some jurisdictions.

5-MeO-DMT is sometimes called toad, the toad, jaguar, or Bufo, referring to the Sonoran Desert toad (Incilius alvarius, formerly Bufo alvarius) whose parotid gland secretions contain 5-MeO-DMT. The compound is chemically related to DMT but produces a distinctly different experience and carries different risks. It is increasingly used in retreat settings that have proliferated since the 2010s. Users may or may not understand that 5-MeO-DMT is pharmacologically distinct from N,N-DMT, and confusion between the two compounds is one reason that careful history-taking matters in clinical assessment.

Common DMT formulations and how to recognise them

Crystalline DMT is the form in which DMT is most commonly sold for smoking or vaporising. The substance appears as a yellowish to white crystalline powder, sometimes described as resembling rock salt or coarse powder. The crystals have a distinct odour often compared to mothballs, burning plastic, or new shoes that some users find unpleasant before the intoxication takes hold. Crystalline DMT is typically sold by weight, with one to two grams being a common purchase quantity providing many doses.

DMT vape pens and DMT carts have become substantially more common since approximately 2018 and represent the formulation most likely to be encountered by parents and clinicians today. The cartridges are similar in appearance to nicotine or THC vape cartridges, containing a clear or amber liquid that the user can vaporise discreetly. The pre-loaded vape pen format substantially reduces the technical barriers to DMT use: no need to learn how to load a glass pipe, no characteristic odour from combustion, and a discreet appearance that does not draw attention. The shift to vape pens has been associated with a younger user population, more frequent use, and lower understanding of the substance’s potency among users.

Changa is a smokable preparation combining crystalline DMT with herbal blends often including Banisteriopsis caapi leaves, mullein, peppermint, or other herbs. The Banisteriopsis caapi component contains harmine and harmaline, which are monoamine oxidase inhibitors that potentiate and prolong the DMT effects compared to pure smoked DMT. The result is an experience that may last 30 to 60 minutes rather than 15 to 30 and may have characteristics intermediate between smoked DMT and ayahuasca. Changa is typically sold in jars or pouches containing the herbal preparation with the DMT already incorporated.

Ayahuasca is a brewed beverage produced by combining DMT-containing plants with Banisteriopsis caapi vine. The traditional preparation involves long simmering of the plant materials to extract the DMT and the MAOI alkaloids. The resulting brew is brown, thick, and has a distinctive bitter taste that most users find unpleasant. The brew is taken orally rather than smoked, and the MAOI component allows the DMT to be active orally by inhibiting the gut and liver enzymes that would otherwise destroy it on first pass. The experience lasts four to six hours and is traditionally taken in a ceremonial setting with a shaman or ceremony leader.

Pharmahuasca is a term used for laboratory-prepared combinations of pure synthetic DMT with a synthetic MAOI such as moclobemide or harmine, taken in capsule form. Pharmahuasca produces a similar four to six hour experience to ayahuasca without the unpleasant taste and with more predictable dosing. The MAOI component carries significant medical risks including hypertensive crisis when combined with certain foods, medications, and other substances, and pharmahuasca preparation requires substantially more pharmacological knowledge than recreational users typically have.

Typical patterns of DMT use and the user populations

DMT use spans several distinct populations with different patterns of use and different risk profiles. The traditional ceremonial population uses ayahuasca in structured religious or healing settings, typically once or a few times per year, with significant preparation and integration support. This population includes adherents of Santo Daime and União do Vegetal in South America and members of those traditions internationally, as well as participants in ayahuasca retreats that have proliferated globally since the 2000s. Risks in this population are moderated by the ceremonial structure and the careful screening that responsible retreat operators provide.

The psychonaut population uses crystalline DMT and changa for self-directed exploration of consciousness, often guided by online communities and influenced by writers including Terence McKenna and Rick Strassman. Use frequency in this population varies from rare to monthly to weekly, with most experienced users emphasising the importance of preparation, intention, and integration. Risks in this population include hallucinogen persisting perception disorder, psychiatric decompensation in vulnerable individuals, and the accumulation of disorienting experiences without adequate processing support.

The recreational and festival population uses DMT vape pens, crystalline DMT in social settings, and 5-MeO-DMT at retreat events in a less structured manner. This population overlaps substantially with the broader psychedelic and MDMA festival culture. Use is often combined with cannabis, alcohol, MDMA, or other substances, and the lack of ceremonial structure means that many users have intense or destabilising experiences without adequate support. The vape pen format has expanded this population substantially because the technical barriers to use are minimal.

The emerging concern is a younger adolescent and young adult population using DMT vape pens casually, often without understanding the substance’s potency, without preparing for the experience, and without integration support. Clinical reports of disturbing or destabilising experiences in this population have increased since approximately 2020. Parents of adolescents and young adults should be aware of the vape pen format because it can be mistaken for a nicotine or cannabis vape and may not be recognised as containing a powerful hallucinogenic substance.

Acute effects and the typical DMT experience

Smoked or vaporised DMT produces an intense experience with a rapid onset of approximately 30 seconds, a peak around two to five minutes, and a return to baseline within 15 to 45 minutes depending on dose. The effects are described by users as a complete dissolution of ordinary reality, often with a sense of being launched into an alternative dimension. Visual phenomena are central, including geometric patterns, vibrant colours, and visions of beings, entities, or what users describe as autonomous intelligences. The experience often includes profound emotional content, sensations of expanded awareness, and reports of contact with what feels like a divine or alien intelligence.

Physical effects include elevated heart rate and blood pressure, dilated pupils, increased body temperature, possible nausea, and occasional vomiting particularly with ayahuasca. The cardiovascular load is meaningful and the substance is not recommended for people with significant cardiovascular disease, uncontrolled hypertension, or recent heart attack or stroke. Death directly attributable to DMT use is rare but has been reported in cases involving cardiovascular events, accidents during the intoxicated state, and combinations with other substances.

Ayahuasca produces a different experience profile because of the longer duration and the MAOI component. The experience builds gradually over the first hour, with the peak typically occurring at two to three hours and the return to baseline over the subsequent two to three hours. Vomiting and diarrhea are common and are framed in the traditional context as la purga, a cleansing aspect of the experience. The psychological content is similar to smoked DMT but the longer duration allows for more sustained engagement with the visions, often described by users as a teaching or therapeutic encounter.

5-MeO-DMT produces a distinctly different experience that some users describe as more annihilating and less visually rich than N,N-DMT. The experience is often described as ego death without the visionary content. The cardiovascular effects are more pronounced than with N,N-DMT and the risk profile differs accordingly. 5-MeO-DMT also has potentially dangerous interactions with serotonergic medications including SSRIs and other antidepressants, and serotonin syndrome has been reported with these combinations.

Risks and adverse effects of DMT use

The acute medical risks of DMT use are concentrated in the cardiovascular system and in the psychological response to the intense experience. Hypertensive crisis, tachycardia, and arrhythmias have all been reported, particularly with ayahuasca combined with serotonergic medications or with sympathomimetic substances. Behavioural risks during the acute intoxication include falls, drowning, traffic accidents if the person attempts to drive or operate machinery, and inability to call for help if a medical emergency develops during the trip. Combined use with other substances substantially increases all of these risks.

Psychological risks include acute panic and traumatic experiences, sometimes referred to as bad trips, which can be intensely distressing during the experience and can leave the person with lasting anxiety or post-traumatic symptoms afterward. Hallucinogen persisting perception disorder is a recognised diagnosis in the DSM-5 in which perceptual disturbances such as visual snow, palinopsia, and trailing of objects persist for weeks, months, or years after use. The risk is not well-characterised for DMT specifically but is reported in users and is associated with frequent use, high doses, and use of multiple hallucinogens.

Precipitation or worsening of serious mental illness is the most clinically important risk, particularly in young people with personal or family history of psychotic illness, bipolar disorder, or major depression. DMT can precipitate a first psychotic episode in a vulnerable individual, can worsen pre-existing psychosis, and can trigger manic episodes in people with bipolar disorder. The relationship between cannabis use and psychotic illness has been studied extensively; the relationship for DMT and other classic hallucinogens is less well-studied but follows similar principles. Family history of any psychotic illness is a relative contraindication to DMT use.

Addiction potential and the question of DMT dependence

DMT has lower abuse liability than the major substances of abuse including opioids, stimulants, alcohol, benzodiazepines, and nicotine. The acute experience is too intense to be used continuously in the way that other drugs are used, tolerance develops rapidly so repeated dosing within hours or days produces diminishing returns, and the substance does not produce the dopamine surge in the brain reward circuit that underlies most addictive drug use. Most users report that the experience does not produce craving in the way that other drugs do.

Nevertheless, psychological dependence on DMT is possible and is reported in clinical settings. Some users develop a pattern of frequent use, often weekly or more, in which the DMT experience becomes a central focus of life and other activities are neglected. The compulsive seeking of additional mystical or transformative experiences, the integration of identity around being a psychonaut, and the difficulty engaging with ordinary life between trips can all produce a use pattern that meets criteria for hallucinogen use disorder in the DSM-5.

Concurrent substance use is the more common clinical concern. DMT users frequently use other substances including cannabis, MDMA, alcohol, and prescription medications. The polysubstance use pattern carries substantially more risk than DMT use alone, and treatment in this population requires attention to the whole pattern rather than to any single substance. Phuket Island Rehab provides residential addiction medicine treatment for polysubstance use including hallucinogens, cannabis, alcohol, and other drugs, with attention to the mental health concerns and existential crises that often co-occur with intensive psychedelic use.

Recognising DMT use in family members

Family members who suspect DMT use may notice several characteristic indicators. The crystalline form has a distinctive odour and the smoke from combustion has an unpleasant character that users sometimes describe as resembling burning plastic or new shoes. Glass pipes designed for smoking DMT have a characteristic appearance with a wide bowl to hold the crystals. DMT vape pens look like ordinary nicotine or THC vape pens and may not be immediately recognisable as containing a different substance; the cartridge liquid may be clear or amber and may be more viscous than nicotine or THC cartridges.

Behavioural signs of DMT use are less specific than the signs of stimulant or opioid use. People who use DMT may have a heightened interest in spirituality, consciousness, philosophy, or alternative belief systems, may discuss psychedelic ideas or DMT-related concepts using terminology drawn from online psychonaut communities, and may show changes in social network toward people interested in psychedelics. The use itself is usually private and the intoxication brief, so direct observation of the use is less common than with substances used in social settings.

Concerning patterns that warrant clinical assessment include frequent use without significant breaks for integration, persistent perceptual disturbances such as visual snow or flashbacks, the development of grandiose or delusional belief systems particularly around messianic missions or contact with spiritual entities, neglect of work or relationships in favour of pursuit of additional psychedelic experiences, and any signs of psychiatric decompensation including mood instability, paranoia, or disorganised thinking. Adolescents using DMT vape pens are at particular risk because the technical barriers to use are minimal and the integration and preparation that experienced users emphasise are typically absent.

When DMT use coexists with alcohol or polysubstance use

Alcohol use disorder, which is the clinical term for what most people call alcoholism, frequently coexists with hallucinogen use including DMT. The pattern of heavy drinking in everyday life with occasional or frequent psychedelic exploration is common in the psychonaut population, and many users do not see themselves as having a problem with alcohol despite drinking patterns that meet DSM-5 criteria for moderate or severe alcohol use disorder. The DMT use may itself be partly an attempt to find meaning or relief from a daily life dominated by drinking, and treating only the DMT without addressing the alcohol typically fails.

Treatment options for alcohol use disorder co-occurring with hallucinogen use include outpatient counselling, intensive outpatient programs, medications including naltrexone and acamprosate, and residential rehab for cases that have not responded to outpatient care. The integrated treatment of both conditions produces better outcomes than treating either in isolation. Phuket Island Rehab provides residential addiction medicine treatment for international patients with alcohol use disorder, hallucinogen use, and the underlying anxiety, depression, or existential concerns that often drive both.

Summary

DMT is N,N-dimethyltryptamine, a powerful naturally-occurring hallucinogen sold under many street names including the spirit molecule, businessman’s trip, dimitri, fantasia, and the god molecule. The substance comes in several distinct formulations including crystalline DMT, DMT vape pens, changa, ayahuasca, and 5-MeO-DMT, each with different patterns of use and different risk profiles. The DMT vape pen format has substantially expanded the user population since approximately 2018 and represents the formulation most likely to be encountered by parents and clinicians today. Although DMT has lower abuse liability than most other controlled substances, regular use can produce psychological dependence, contribute to hallucinogen persisting perception disorder, and precipitate or worsen serious mental illness in vulnerable individuals. Concurrent alcohol and other substance use is the more common clinical concern in this population, and integrated addiction medicine treatment that addresses the whole pattern is the most effective approach. As Dr. Ponlawat Pitsuwan summarises, “Recognising the street names and the formulations is the first step in any clinical assessment of suspected DMT use. The vape pen format has changed the user population substantially in recent years and many of the people now using DMT do not have the preparation and integration support that historically governed responsible use of the substance.”

Frequently asked questions

What is DMT called on the street?

Common street names for DMT include the spirit molecule, the god molecule, dimitri, fantasia, the businessman’s trip or businessman’s lunch, 45-minute psychosis, the businessman’s special, and simply DMT. Ayahuasca is sometimes called aya, the medicine, the vine, the tea, hoasca, or vine of the soul. 5-MeO-DMT, a related but distinct compound, is sometimes called toad, the toad, jaguar, or Bufo.

What does DMT look like?

Crystalline DMT appears as a yellowish to white crystalline powder resembling rock salt or coarse powder, with a distinctive odour often compared to mothballs or burning plastic. DMT vape pens and cartridges look like ordinary nicotine or THC vape pens but contain a clear or amber liquid that vaporises the substance. Ayahuasca is a brown thick bitter-tasting tea. Changa is a smokable herbal mixture that incorporates DMT into a base of mullein, mint, or other herbs.

Is DMT addictive?

DMT has lower abuse liability than most controlled substances. Tolerance develops rapidly so repeated dosing within hours produces diminishing returns, and the substance does not produce the dopamine surge in the brain reward circuit that underlies most addictive drug use. Psychological dependence is possible and is reported in clinical settings, particularly in users who develop a pattern of frequent use that crowds out other activities. Concurrent substance use including alcohol, cannabis, and MDMA is the more common clinical concern.

How long does a DMT trip last?

Smoked or vaporised DMT produces an intense experience lasting 15 to 45 minutes including come-up, peak, and return to baseline. Changa lasts somewhat longer, typically 30 to 60 minutes, because the herbal MAOI component prolongs the effect. Ayahuasca lasts four to six hours from onset to return to baseline because the oral route and MAOI component produce a fundamentally different time course. 5-MeO-DMT lasts approximately 20 to 30 minutes when vaporised.

Can DMT cause mental illness?

DMT can precipitate a first psychotic episode in a vulnerable individual, can worsen pre-existing psychosis or bipolar illness, and is associated with hallucinogen persisting perception disorder in some users. The risk is highest in adolescents and young adults with personal or family history of psychotic illness, schizophrenia, bipolar disorder, or major depression. Anyone with these vulnerabilities should not use DMT or related hallucinogens without psychiatric assessment.

Is DMT legal anywhere?

DMT is illegal for non-research use in most countries. Some jurisdictions including the United States and Brazil provide limited religious exemptions for ayahuasca use by established religious traditions including Santo Daime and União do Vegetal. The legal status of psilocybin and other hallucinogens is changing in some jurisdictions including Oregon and several cities, but DMT specifically remains tightly controlled. Research-related use in clinical trials is legal in many countries under regulatory oversight.

Sources

• U.S. Drug Enforcement Administration (DEA). N,N-Dimethyltryptamine (DMT) drug fact sheet. https://www.dea.gov/factsheets/dimethyltryptamine
• Strassman R. DMT: The Spirit Molecule. Park Street Press; 2001.
• National Institute on Drug Abuse (NIDA). Hallucinogens. https://nida.nih.gov/research-topics/hallucinogens
• dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC. Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews. Expert Review of Clinical Pharmacology. 2018;11(9):889-902. https://www.tandfonline.com/doi/full/10.1080/17512433.2018.1511424
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). Arlington, VA: American Psychiatric Publishing; 2013.
• Substance Abuse and Mental Health Services Administration (SAMHSA). National Helpline. https://www.samhsa.gov/find-help/national-helpline
• Halpern JH, Pope HG Jr. Hallucinogen persisting perception disorder: what do we know after 50 years? Drug and Alcohol Dependence. 2003;69(2):109-119. https://www.sciencedirect.com/science/article/abs/pii/S0376871602002975

DMT, N,N-dimethyltryptamine, dimethyltryptamine, 5-MeO-DMT, ayahuasca, changa, spirit molecule, god molecule, dimitri, businessman’s trip, businessman’s lunch, fantasia, 45-minute psychosis, hoasca, yagé, the medicine, the vine, the tea, vine of the soul, Bufo, Sonoran Desert toad, Incilius alvarius, Banisteriopsis caapi, Psychotria viridis, Diplopterys cabrerana, Mimosa hostilis, monoamine oxidase inhibitor, MAOI, harmine, harmaline, moclobemide, pharmahuasca, tryptamine, serotonin, 5-HT2A receptor, hallucinogen, psychedelic, psilocybin, mushrooms, LSD, mescaline, MDMA, Schedule I controlled substance, DEA, FDA, Rick Strassman, Terence McKenna, Santo Daime, União do Vegetal, UDV, ceremony, retreat, psychonaut, hallucinogen use disorder, hallucinogen persisting perception disorder, HPPD, visual snow, palinopsia, bad trip, ego death, psychosis, schizophrenia, bipolar disorder, major depression, serotonin syndrome, SSRI, antidepressant, alcohol use disorder, polysubstance use, cannabis, DSM-5, NIDA, SAMHSA, NHS, residential rehab, Phuket Island Rehab, addiction medicine, dual diagnosis, vape pen, DMT cart, glass pipe.